Supernus Pharmaceuticals Inventory 2011-2024 | SUPN
Supernus Pharmaceuticals inventory from 2011 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
Supernus Pharmaceuticals Annual Inventory
(Millions of US $) |
| 2023 |
$77 |
| 2022 |
$92 |
| 2021 |
$86 |
| 2020 |
$48 |
| 2019 |
$27 |
| 2018 |
$26 |
| 2017 |
$16 |
| 2016 |
$17 |
| 2015 |
$13 |
| 2014 |
$13 |
| 2013 |
$7 |
| 2012 |
$1 |
| 2011 |
$ |
| 2010 |
$ |
Supernus Pharmaceuticals Quarterly Inventory
(Millions of US $) |
| 2024-09-30 |
$64 |
| 2024-06-30 |
$68 |
| 2024-03-31 |
$75 |
| 2023-12-31 |
$77 |
| 2023-09-30 |
$83 |
| 2023-06-30 |
$91 |
| 2023-03-31 |
$91 |
| 2022-12-31 |
$92 |
| 2022-09-30 |
$83 |
| 2022-06-30 |
$85 |
| 2022-03-31 |
$89 |
| 2021-12-31 |
$86 |
| 2021-09-30 |
$60 |
| 2021-06-30 |
$58 |
| 2021-03-31 |
$50 |
| 2020-12-31 |
$48 |
| 2020-09-30 |
$42 |
| 2020-06-30 |
$35 |
| 2020-03-31 |
$24 |
| 2019-12-31 |
$27 |
| 2019-09-30 |
$26 |
| 2019-06-30 |
$26 |
| 2019-03-31 |
$27 |
| 2018-12-31 |
$26 |
| 2018-09-30 |
$23 |
| 2018-06-30 |
$21 |
| 2018-03-31 |
$19 |
| 2017-12-31 |
$16 |
| 2017-09-30 |
$15 |
| 2017-06-30 |
$17 |
| 2017-03-31 |
$19 |
| 2016-12-31 |
$17 |
| 2016-09-30 |
$17 |
| 2016-06-30 |
$16 |
| 2016-03-31 |
$13 |
| 2015-12-31 |
$13 |
| 2015-09-30 |
$15 |
| 2015-06-30 |
$14 |
| 2015-03-31 |
$14 |
| 2014-12-31 |
$13 |
| 2014-09-30 |
$11 |
| 2014-06-30 |
$10 |
| 2014-03-31 |
$8 |
| 2013-12-31 |
$7 |
| 2013-09-30 |
$5 |
| 2013-06-30 |
$4 |
| 2013-03-31 |
$3 |
| 2012-12-31 |
$1 |
| 2012-09-30 |
$0 |
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.978B |
$0.608B |
|
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
|
